Format

Send to

Choose Destination
See comment in PubMed Commons below
J Zhejiang Univ Sci B. 2012 Sep;13(9):663-75.

Molecular biomarkers of colorectal cancer: prognostic and predictive tools for clinical practice.

Author information

1
Cancer Center, the First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.

Abstract

Colorectal cancer remains one of the most common types of cancer and leading causes of cancer death worldwide. Although we have made steady progress in chemotherapy and targeted therapy, evidence suggests that the majority of patients undergoing drug therapy experience severe, debilitating, and even lethal adverse drug events which considerably outweigh the benefits. The identification of suitable biomarkers will allow clinicians to deliver the most appropriate drugs to specific patients and spare them ineffective and expensive treatments. Prognostic and predictive biomarkers have been the subjects of many published papers, but few have been widely incorporated into clinical practice. Here, we want to review recent biomarker data related to colorectal cancer, which may have been ready for clinical use.

PMID:
22949358
PMCID:
PMC3437365
DOI:
10.1631/jzus.B1100340
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Zhejiang University Press Icon for PubMed Central
    Loading ...
    Support Center